NCT04781153

Brief Summary

The purpose of this study is to investigate if treatment of periodontitis (gum disease) in a relatively young and healthy population can improve lung function. It is hypothesized that removing the dental biofilm reduce the source of inflammatory bacteria that can reach the lungs, and thereby reduce lung inflammation and lead to improved lung function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 4, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

April 27, 2021

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 27, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 27, 2024

Completed
Last Updated

February 6, 2025

Status Verified

December 1, 2024

Enrollment Period

3.2 years

First QC Date

February 19, 2021

Last Update Submit

February 3, 2025

Conditions

Keywords

PeriodontitisOral healthLung functionRespiratory healthPeriodontal treatmentMicrobiomeOral hygiene

Outcome Measures

Primary Outcomes (3)

  • Forced Vital Capacity (FVC) (L)

    Change in Forced vital capacity in liters (L).

    Baseline, 3 weeks, 6 weeks, 3 months, 6 months, 9 months and 12 months

  • Forced Expiratory Volume in one second (FEV1) (L)

    Change in Forced expiratory volume in one second in liters (L).

    Baseline, 3 weeks, 6 weeks, 3 months, 6 months, 9 months and 12 months

  • Forced Oscillation Technique (FOT)

    Change in lung function measured by Forced Oscillation Technique (FOT). Outcome parameters are: Resistance at 5Hz (R5) \[kPaL-1s\] Resistance at 20Hz (R20) \[kPaL-1s\] Reactance at 5 Hz (X5) \[kPaL-1s\] Reactance area AX \[kPaL-1\] and Resonance frequency (fres) \[Hz\].

    Baseline, 3 weeks, 6 weeks, 3 months, 6 months, 9 months and 12 months

Secondary Outcomes (2)

  • Sampling of plaque bacteria

    Change from baseline at 6 months

  • Fractional exhaled nitric oxide (FeNO)

    Baseline, 3 weeks, 6 weeks, 3 months, 6 months, 9 months and 12 months

Study Arms (2)

Immediate intervention (A)

EXPERIMENTAL

Subjects will receive the full mouth disinfection treatment protocol (scaling and rootplaning of all periodontal pockets with adjunctive use of chlorhexidine mouthwash) immediately after baseline.

Procedure: Periodontal treatment

Delayed intervention (B)

EXPERIMENTAL

Subjects will receive a full mouth disinfection treatment protocol (scaling and rootplaning of all periodontal pockets with adjunctive use of chlorhexidine mouthwash) 3-4 weeks after baseline. The "delayed intervention" will enable the study team to explore the effect of the participants change in behavior due to participation in a research project, and furthermore how change in oral hygiene habits might affect the lung function.

Procedure: Periodontal treatment

Interventions

Periodontal treatment (scaling and rootplaning) with adjunctive chlorhexidine use

Delayed intervention (B)Immediate intervention (A)

Eligibility Criteria

Age25 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • clinical diagnosis of periodontitis (stadium I or II)
  • measures of periodontal infection (PI) \> 50%
  • inflammation (bleeding index/bleeding on probing) \> 50%
  • never-smoker

You may not qualify if:

  • asthma
  • symptoms of pollen allergy
  • chronic lung diseases
  • daily medication use which may interfere with the evaluation of the subject
  • pregnancy
  • use of systemic antibiotics last six months
  • subgingival scaling last six months
  • regularly use of oral antiseptic mouth rinse
  • use of snus (moist/smokeless tobacco)
  • current medical condition which may interfere with the evaluation of the subject

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Clinical Dentistry, University of Bergen

Bergen, BERGEN, 5009, Norway

Location

Related Publications (1)

  • Rosland A, Bertelsen RJ, Heinrich J, Lie SA, Malinovschi A, Bunaes DF. Effect of periodontal therapy on lung function: a twelve-month follow-up intervention study. Respir Res. 2025 May 3;26(1):172. doi: 10.1186/s12931-025-03246-1.

MeSH Terms

Conditions

PeriodontitisAirway ObstructionPneumonia

Interventions

Periodontal Index

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesRespiratory InsufficiencyRespiration DisordersRespiratory Tract DiseasesRespiratory Tract InfectionsInfectionsLung Diseases

Intervention Hierarchy (Ancestors)

Dental Health SurveysHealth SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesDentistryPeriodonticsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPublic Health Dentistry

Study Officials

  • Randi Jacobsen Bertelsen, PhD

    University of Bergen

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Masking Details
The preventive intervention - professional tooth cleaning - cannot be blinded, but the outcome measure (lung function tests) are blinded for the operator/investigator.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This is a single-blinded longitudinal intervention study with two study groups. The participants will act as their own control as they enter the study with the same periodontal diagnose and receive the same periodontal treatment during the study period. The study does not aim to explore the effect of the periodontal treatment itself, but how removal of oral bacteria affects lung function. After randomization the participants in the first study arm will be moved directly into an active periodontal treatment phase including a scaling and rootplaning with adjunctive chlorhexidine. The second study arm will receive the intervention 3-4 weeks after the first study group - as a "delayed intervention group". At the first appointment they will receive prophylactic periodontal treatment and oral hygiene instructions. This will enable comparison between the immediate intervention group with the delayed intervention (oral hygiene motivation), which serves as the control group.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dentist and clinical researcher

Study Record Dates

First Submitted

February 19, 2021

First Posted

March 4, 2021

Study Start

April 27, 2021

Primary Completion

June 27, 2024

Study Completion

June 27, 2024

Last Updated

February 6, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Due to the relatively small number of participants that will be enrolled in the present study, we cannot make individual participant data openly available. However, other researcher can contact us if they are interested in discussing the possibility of getting access to the data.

Locations